BioFish Holding AS Logo

BioFish Holding AS

BFISH.OL

(1.2)
Stock Price

1,12 NOK

-8.34% ROA

-10.63% ROE

-5.61x PER

Market Cap.

120.047.300,00 NOK

29.05% DER

0% Yield

-47.84% NPM

BioFish Holding AS Stock Analysis

BioFish Holding AS Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

BioFish Holding AS Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.48x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a minimal amount of debt (26%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

4 ROE

The stock's ROE indicates a negative return (-3.98%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-2.71%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-4) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

BioFish Holding AS Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

BioFish Holding AS Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

BioFish Holding AS Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

BioFish Holding AS Revenue
Year Revenue Growth
2017 7.467.007
2018 12.710.274 41.25%
2019 17.521.223 27.46%
2020 30.923.355 43.34%
2021 18.329.596 -68.71%
2022 20.243.664 9.46%
2023 110.304.000 81.65%
2023 47.684.000 -131.32%
2024 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

BioFish Holding AS Research and Development Expenses
Year Research and Development Expenses Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

BioFish Holding AS General and Administrative Expenses
Year General and Administrative Expenses Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

BioFish Holding AS EBITDA
Year EBITDA Growth
2017 2.783.870
2018 2.108.172 -32.05%
2019 3.605.218 41.52%
2020 9.361.498 61.49%
2021 -7.384.149 226.78%
2022 -15.097.335 51.09%
2023 46.828.000 132.24%
2023 -9.406.000 597.85%
2024 -32.156.000 70.75%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

BioFish Holding AS Gross Profit
Year Gross Profit Growth
2017 4.290.372
2018 6.145.675 30.19%
2019 7.368.472 16.59%
2020 17.628.909 58.2%
2021 6.929.191 -154.42%
2022 -981.792 805.77%
2023 62.048.000 101.58%
2023 -14.514.000 527.5%
2024 -13.328.000 -8.9%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

BioFish Holding AS Net Profit
Year Net Profit Growth
2017 1.637.680
2018 1.143.231 -43.25%
2019 2.439.838 53.14%
2020 6.814.613 64.2%
2021 -5.787.105 217.76%
2022 -14.891.214 61.14%
2023 32.332.000 146.06%
2023 -17.827.000 281.37%
2024 -51.488.000 65.38%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

BioFish Holding AS Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 -1 0%
2023 0 0%
2023 0 0%
2024 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

BioFish Holding AS Free Cashflow
Year Free Cashflow Growth
2018 -39.687.613
2019 -8.270.270 -379.88%
2020 -8.203.576 -0.81%
2021 -100.818.459 91.86%
2022 -43.720.864 -130.6%
2023 4.555.000 1059.84%
2023 -64.773.000 107.03%
2024 -17.822.000 -263.44%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

BioFish Holding AS Operating Cashflow
Year Operating Cashflow Growth
2018 18.653.718
2019 28.013.294 33.41%
2020 13.324.467 -110.24%
2021 -72.384.758 118.41%
2022 1.946.637 3818.45%
2023 10.072.000 80.67%
2023 -18.893.000 153.31%
2024 -15.917.000 -18.7%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

BioFish Holding AS Capital Expenditure
Year Capital Expenditure Growth
2018 58.341.331
2019 36.283.564 -60.79%
2020 21.528.043 -68.54%
2021 28.433.701 24.29%
2022 45.667.501 37.74%
2023 5.517.000 -727.76%
2023 45.880.000 87.98%
2024 1.905.000 -2308.4%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

BioFish Holding AS Equity
Year Equity Growth
2017 10.777.370
2018 11.919.963 9.59%
2019 14.152.351 15.77%
2020 20.966.325 32.5%
2021 158.364.764 86.76%
2022 143.473.550 -10.38%
2023 213.244.000 32.72%
2023 194.632.000 -9.56%
2024 192.762.000 -0.97%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

BioFish Holding AS Assets
Year Assets Growth
2017 21.469.835
2018 97.102.424 77.89%
2019 129.855.416 25.22%
2020 142.026.935 8.57%
2021 222.014.174 36.03%
2022 219.294.216 -1.24%
2023 279.360.000 21.5%
2023 259.259.000 -7.75%
2024 256.848.000 -0.94%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

BioFish Holding AS Liabilities
Year Liabilities Growth
2017 10.692.465
2018 85.182.461 87.45%
2019 115.703.065 26.38%
2020 121.060.610 4.43%
2021 63.649.410 -90.2%
2022 75.820.666 16.05%
2023 66.116.000 -14.68%
2023 64.626.999 -2.3%
2024 64.405.000 -0.34%

BioFish Holding AS Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.44
Net Income per Share
-0.21
Price to Earning Ratio
-5.61x
Price To Sales Ratio
2.68x
POCF Ratio
-6.38
PFCF Ratio
-3.63
Price to Book Ratio
0.62
EV to Sales
3.85
EV Over EBITDA
-41.76
EV to Operating CashFlow
-9.17
EV to FreeCashFlow
-5.22
Earnings Yield
-0.18
FreeCashFlow Yield
-0.28
Market Cap
0,12 Bil.
Enterprise Value
0,17 Bil.
Graham Number
3
Graham NetNet
-0.49

Income Statement Metrics

Net Income per Share
-0.21
Income Quality
0.88
ROE
-0.11
Return On Assets
-0.08
Return On Capital Employed
-0.07
Net Income per EBT
0.99
EBT Per Ebit
1.32
Ebit per Revenue
-0.37
Effective Tax Rate
-0.26

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.15
Operating Profit Margin
-0.37
Pretax Profit Margin
-0.49
Net Profit Margin
-0.48

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.18
Free CashFlow per Share
-0.33
Capex to Operating CashFlow
-0.76
Capex to Revenue
0.32
Capex to Depreciation
1.16
Return on Invested Capital
-0.08
Return on Tangible Assets
-0.08
Days Sales Outstanding
13.43
Days Payables Outstanding
50.35
Days of Inventory on Hand
191.23
Receivables Turnover
27.18
Payables Turnover
7.25
Inventory Turnover
1.91
Capex per Share
0.14

Balance Sheet

Cash per Share
0,03
Book Value per Share
1,89
Tangible Book Value per Share
1.89
Shareholders Equity per Share
1.89
Interest Debt per Share
0.6
Debt to Equity
0.29
Debt to Assets
0.22
Net Debt to EBITDA
-12.7
Current Ratio
1.44
Tangible Asset Value
0,19 Bil.
Net Current Asset Value
-0,04 Bil.
Invested Capital
239443000
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,01 Bil.
Average Inventory
14955500
Debt to Market Cap
0.47

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

BioFish Holding AS Dividends
Year Dividends Growth

BioFish Holding AS Profile

About BioFish Holding AS

Biofish Holding AS produces and sells smolt for the salmon farming industry. The company was founded in 2016 and is based in Tørvikbygd, Norway.

CEO
Mr. Sondre Hagerup Johnsrud
Employee
11
Address
Tangavegen 19
Tørvikbygd, 5620

BioFish Holding AS Executives & BODs

BioFish Holding AS Executives & BODs
# Name Age
1 Ms. Lena Hovda Aas
Operations Manager
70
2 Mr. Johnny Duedahl
Chief Financial Officer
70
3 Mr. Sondre Hagerup Johnsrud
Chief Executive Officer
70

BioFish Holding AS Competitors

Icelandic Salmon AS Logo
Icelandic Salmon AS

ISLAX.OL

(2.5)
Ensurge Micropower ASA Logo
Ensurge Micropower ASA

ENSU.OL

(2.5)
Gigante Salmon AS Logo
Gigante Salmon AS

GIGA.OL

(1.5)